ProAlt’s MetasCure project selected in the R&D and innovation programme of Madrid Region
January 14th, 2021 Tres Cantos, Madrid, Spain. Protein Alternatives (PROALT), a leading company in [...]
Protein Alternatives announces the opening of new office in Boston
December 1st, 2020 Tres Cantos, Madrid, Spain. Protein Alternatives (PROALT), a leading company in [...]
METASTCURE colon cancer therapeutic project receives the Seal of Excellence recognition from the EU H2020 Programme
November 25th, 2020 PROALT’s project proposal named ‘METASTCURE – Anti cadherin-RGD monoclonal antibody PA-0661 [...]
PROALT participates in BIO-Europe® Digital
October 26th, 2020 BIO-Europe is the largest partnering conference in Europe dedicated to the [...]
PROALT participates in AseBio Investor Day 2020
September 28th, 2020 AseBio Investor Day 2020 is a digital event from September 28th [...]
PROFILUX Lung Cancer diagnostic project receives funding from the EU Eurostars Programme and CDTI
April 1st, 2020 The project proposal named ‘PROFILUX – Saliva- and blood-based lung cancer [...]